|Institutional Source||Beutler Lab|
|Gene Name||forkhead box A1|
|Synonyms||Hnf3a, Hnf-3a, Tcf3a, Tcf-3a|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Stock #||R7864 (G1)|
|Chromosomal Location||57540628-57546916 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to T at 57542747 bp|
|Amino Acid Change||Valine to Aspartic acid at position 229 (V229D)|
|Ref Sequence||ENSEMBL: ENSMUSP00000041118 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000044380]|
|Predicted Effect||probably damaging
AA Change: V229D
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: V229D
|Coding Region Coverage||
|Validation Efficiency||100% (48/48)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific transcripts such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygotes for targeted null mutations exhibit abnormal feeding, hypoglycemia, impaired glucagon secretion, hypotryglyceridemia, wasting, and lethality between postnatal days 2 and 14. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Foxa1||
(F):5'- GAGACTTCAACTCCGAAGCG -3'
(R):5'- GACGCCAAGACATTCAAGCG -3'
(F):5'- CGCTGTGGTCCAGAGTCTG -3'
(R):5'- GCCAAGCCGCCTTACTC -3'